gestalt: I think you are correct in your assessment of Nader. That being said, I once again trust that Pestell did his DD and isn't selling his company into a black hole of completely inept management, now that he is coming onboard. Trials take time and money, the science seems to clearly be there, and hopefully now we have more forward momentum with Prostagene and Pestell. Cautious optimism at the least.